Skip to main content
# Title Department Research Year
121 New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents Department of Pharmaceutical Organic Chemistry 2022
122 Novel Azine Linked Hybrids of 2-indolinone and Thiazolodinone Scaffolds as CDK2 Inhibitors with Potential Anticancer Activity: In Silico Design, Synthesis, Biological, Molecular Dynamics and Binding Free Energy Studies Department of Medicinal Chemistry 2022
123 Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies Department of Pharmaceutical Organic Chemistry 2022
124 Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice Department of Pharmacology 2022
125 New 1, 2, 4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity Department of Pharmaceutical Organic Chemistry 2022
126 Electrochemical sensing of copper-chelator D- penicillamine based on complexation with gold nanoparticles modified copper based-metal organic frameworks Department of Pharmaceutical Analytical Chemistry 2022
127 A Novel C Fe Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma Department of Industrial Pharmacy 2022
128 Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties Department of Pharmaceutical Organic Chemistry 2022
129 Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 complex from SARS-CoV-2. 2022
130 Elegant, Flexible Vesicular Nanocarriers for the Efficient Skin Delivery of Topically Applied Drugs Department of Pharmaceutics 2022